Slim chance in the pharma dance

Slim chance in the pharma dance

🔒 Sign in to unlock interactive practice
Start typed mock interview Download peer practice PDF

YOUR ATTEMPTS

Rate this case

Slim chance in the pharma dance

Written by the Experts at RocketBlocks
Published: 11-21-2024
Slim chance in the pharma dance

Slim chance in the pharma dance

🔒 Sign in to unlock interactive practice

YOUR ATTEMPTS

Rate this case

Overview

Your client, MedEx Innovations, is preparing to launch Slimvora, a GLP-1 weight loss drug expected to compete with Ozempic and Wegovy. After investing $8 billion in development, MedEx has hired your firm to design a launch strategy that maximizes return on investment and captures untapped market demand.

Formats available

Typed mock interview

Peer practice PDF

🎥Expert mock video

Case info

Difficulty

Intermediate

Case type

Market entry, Market sizing

Industry

Pharmaceuticals

Company

Novo Nordisk

Geography

North America, USA

Additional info

Includes charts and/or data analysis


Video mock interview with Experts

💡

Tip: Try cases on your own before watching Expert videos to maximize learning.

Featured Experts

Ben Wilson | Mid Career Expert

White House Presidential Innovation Fellow | ex-Alvarez & Marsal | ex-EY-P

Christopher MacRae Ham | Mid Career Expert

Strategy & Development Manager - Energy Infrastructure


P.S. Are you preparing for consulting interviews?

Real interview drills. Sample answers from ex-McKinsey, BCG and Bain consultants. Plus technique overviews and premium 1-on-1 Expert coaching.

Return to all cases